Joseph Lieberman said...
But we are not--I mean, one of the major recommendations that comes out of this is that we still have not figured out how to leverage the ingenuity and innovation of the pharmaceutical sector of our economy to get involved in developing medical countermeasures to diseases that in some sense are hypothetical.
Context
Lieberman emphasizes the need for pharmaceutical innovation in medical countermeasures.
10/27/2015